11 Best Cannabis Stocks To Invest In

Page 4 of 10

7. Aurora Cannabis Inc. (NASDAQ:ACB)

Number of Hedge Fund Holders: 6

Aurora Cannabis Inc. (NASDAQ:ACB), together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derived products across Canada, Europe, Australia, and South America. The company is the leading provider of medical cannabis to Canadian patients – a market worth over $250 million in fiscal year 2023-24.

Aurora Cannabis Inc. (NASDAQ:ACB) had a strong Q2 2025, ending September 30th, 2024, with total net revenue of $81.1 million, compared to $63.1 million in the prior year period. Medical cannabis, which is the core segment of Aurora, grew 41% YoY to reach $61.3 million. The company’s strategy of going global also seems to be paying off, as its international revenue increased 93% to $35 million, exceeding Canadian medical revenue for the first time and contributing 57% to total global medical cannabis revenue. The only offset came from the consumer cannabis segment, which witnessed a YoY downturn of 13%, but it represents only around 13% of the firm’s total sales.

As a result, Aurora Cannabis Inc. (NASDAQ:ACB) reported a net profit of $1.7 million in the last quarter, a YoY increase of a notable 325%. This means that the company came out with quarterly earnings of $0.04 per share, beating Wall Street analysts’ estimates of a loss of $0.22 per share and topping consensus revenue estimates three times over the last four quarters. It also ended the quarter with approximately $152 million in cash and cash equivalents and no debt in its cannabis business.

Aurora Cannabis Inc. (NASDAQ:ACB) maintains a world-class research and genetics facility in Canada and announced several new medical product advancements last month, keeping its primary focus on the high-margin medical cannabis business.

Page 4 of 10